lasergene seqman protm software (DNASTAR)
DNASTAR is a verified supplier 
DNASTAR manufactures this product 
99
Structured Review
DNASTAR
lasergene seqman protm software
Lasergene Seqman Protm Software, supplied by DNASTAR, used in various techniques. Bioz Stars score: 99/100, based on 10689 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lasergene+seqman+protm+software/Lasergene/pm24052401-39-16-15
Average 99 stars, based on 10689 article reviews
Lasergene Seqman Protm Software, supplied by DNASTAR, used in various techniques. Bioz Stars score: 99/100, based on 10689 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lasergene+seqman+protm+software/Lasergene/pm24052401-39-16-15
Average 99 stars, based on 10689 article reviews
lasergene seqman protm software - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Software:Article Title: Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy. Article Snippet: Defects in dystroglycan post-translational modification result in congenital muscular dystrophy with or without additional eye and brain involvement, are referred to as secondary dystroglycanopathies and have been associated with mutations in 11 different genes encoding glycosyltransferases or associated proteins.. However, only one patient with a mutation in the dystroglycan encoding gene DAG1 itself has been described before.. We here report a homozygous novel DAG1 missense mutation c.2006G>T predicted to result in the amino acid substitution p.Cys669Phe in theβ-subunit of dystroglycan in two Libyan siblings. Variant Assay:Article Title: Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy. Article Snippet: Defects in dystroglycan post-translational modification result in congenital muscular dystrophy with or without additional eye and brain involvement, are referred to as secondary dystroglycanopathies and have been associated with mutations in 11 different genes encoding glycosyltransferases or associated proteins.. However, only one patient with a mutation in the dystroglycan encoding gene DAG1 itself has been described before.. We here report a homozygous novel DAG1 missense mutation c.2006G>T predicted to result in the amino acid substitution p.Cys669Phe in theβ-subunit of dystroglycan in two Libyan siblings. |
